CA2090904C - Dna detection method - Google Patents

Dna detection method Download PDF

Info

Publication number
CA2090904C
CA2090904C CA002090904A CA2090904A CA2090904C CA 2090904 C CA2090904 C CA 2090904C CA 002090904 A CA002090904 A CA 002090904A CA 2090904 A CA2090904 A CA 2090904A CA 2090904 C CA2090904 C CA 2090904C
Authority
CA
Canada
Prior art keywords
sequence
primer
formula
energy
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002090904A
Other languages
French (fr)
Other versions
CA2090904A1 (en
Inventor
Wilhelm Bannwarth
Francis Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2090904A1 publication Critical patent/CA2090904A1/en
Application granted granted Critical
Publication of CA2090904C publication Critical patent/CA2090904C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6818Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates

Abstract

A process for the detection of a nucleic acid sequence in a homogeneous assay format using an energy transfer system is disclosed. This process utilizes a 5' labeled primer containing a selfcomplementary sequence in an amplification process together with a subsequent detection step using a 3' labeled probe for the amplified region. The labels will be close together in space after hybridizing the probe dose to the short piece of double-stranded DNA
resulting from backfolding of the selfcomplementary region of the primer which has been incorporated into the amplified product. The new primer for use in this process is also disclosed.

Description

The present invention relates to a process for amplifying and detecting at least one specific nucleic acid sequence in a sample containing a nucleic acid or a mixture of nucleic acids at least one of which is suspected of containing said sequence, which process comprises:
a) amplifying the nucleic acid sequence to be detected by means of a chain extension reaction utilizing a first oligonucleotide primer of the general formula X-Pc-L-Pp (I) wherein Pp is an oligonucleotide sequence substantially comple-mentary to a part of one strand of the nucleic acid sequence to be detected, Pc is an oligonucleotide sequence substantially comple-mentary to the sequence Pp, L is a non-nucleotidylic linker group selected so as to allow efficient backfolding between the sequence Pc and the primer extension sequence of Pp and to avoid amplification of the backfolding part Pc, and X is an energy donor or acceptor, and a second oligonucleotide primer substantially complementary to a part of the other strand of the nucleic acid sequence to be detected;
b) separating after the last amplification cycle the primer extension products from their complementary sequences to produce single-stranded molecules;
c) treating said single-stranded molecules containing the primer of formula I
above with an oligonucleotide probe of the general formula Y - Pr (II) wherein Y is an energy acceptor, when X in the primer of formula I
is an energy donor, or an energy donor, when X in the primer of formula I is an energy acceptor, and Pr is an oligonucleotide sequence complementary to a part of the amplified single-stranded molecules containing the primer of formula I above and selected so as to guarantee a short distance between X and Y after backfolding of the sequence Pc and hybridization of the sequence Pr to said single-stranded molecules such that an energy transfer can take place, under conditions allowing hybridization of the sequences Pc by backfolding and of Pr to said single-stranded molecules; and Mey/3.2.93 ~~~~9~4 d) determining whether an energy transfer takes place.
The present invention also relates to a primer of the general formula X-Pc-L-Pp (I) wherein Pp is an oligonucleotide sequence substantially comple-mentary to a part of one strand of the nucleic acid sequence to be detected, Pc is an oligonucleotide sequence substantially comple-mentary to the sequence Pp, L is a non-nucleotidylic linker group selected so as to allow efficient backfolding between the sequence Pc and the primer extension sequence of Pp obtained by amplification by means of a polymerase chain reaction and to avoid amplification of the backfolding part Pc, and X is an energy donor or acceptor.
Furthermore, the invention relates to a diagnostic kit for amplifying and detecting at least one specific nucleic acid sequence in a sample containing a nucleic acid or a mixture of nucleic acids at least one of which is suspected of containing said sequence, which kit comprises a first container containing a primer of formula I as defined above and a second container containing a probe of formula II as defind above and means and reagents for amplification by means of a polymerase chain reaction and for detection.
The polymerase chain reaction (PCR) is a very powerful method for the specific amplification of DNA or RNA stretches. The methodology is described in European Patent Applications, Pub. Nos. 201.184, 200.362 and 258.017. One application of this technology is in DNA probe technology to bring up DNA
present in low copy numbers to a detectable level. Numerous diagnostic and scientific applications of this method have been described by H.A. Erlich (Ed.) in PCR Technology-Principles and Applications for DNA Amplification, Stockton Press, USA, 1989 and by M.A. Inis (Ed.) in PCR Protocols, Academic Press, San Diego, USA, 1990.
A desirable goal would be the direct detection of the amplified DNA
without time-consuming separations or transfer steps by a so-called homo-geneous assay format. At the same time the aim is also to replace radioactive labels still mainly utilized in DNA diagnostics by nonradioactive reporter systems thereby extending the applications of this technology. Such a homo-geneous detection system applying intercalating chemiluminescent acridinium esters has been reported by Arnold et al. in Clinical Chemistry 35, 1588 (1989).
Further variations of the homogeneous DNA detection assays are described in a review by B.S. Reckmann in Nachr. Chem. Tech. Lab. 37, 692-702 (1989).
The use of bathophenanthroline-Ru II complexes as nonradioactive label molecules which can be measured with high sensitivity by time-resolved fluorometry has been described by W. Bannwarth et al. in Helv. Chim. Acta 71, 2085-2099 (1988). These complexes can be part of an interactive pair of label molecules allowing energy transfers from suitable donor molecules onto the Ru complex. Since the efficiency of the energy transfer is highly dependent on the distance between donor and acceptor such systems can be applied in investigations of molecule interactions. As a suitable class of donor molecules for the Ru complexes lumazine chromophores have been identified. The possible applicability of this donor/acceptor pairs in the detection of e.g.
DNA
molecules in a homogeneous assay have been described in European Patent Application, Publ. No. 439 036, and in Helvetica Chimica Acta 74, 1991-1999 (1991 ) and 74, 2000-2008 (1991 ) by W. Bannwarth and F. Miiller. With such a combination energy transfers were detected within oligodeoxynucleotides labeled at the 5'-end with a Ru bathophenanthroline complex and possessing lumazine chromophores at different distances from the Ru complex within the oligonucleotide. Furthermore it was demonstrated that this pair of 2o interactive labels can also be applied to detect a target DNA sequence in a hybridization process wherein one probe sequence is equipped with the donor and the other with the acceptor.
An alternative approach using a terbium complex as an energy acceptor and salicylate as an energy donor in a homogeneous DNA detection system 2S has been described by A. Oser and G. Valet in Angewandte Chemie 102, 1I97-1200 (1990).
The processes known for the detection of oligonucleotides in a homogeneous test format employing energy transfers for the subsequent detection make use of at least two labeled oligonucleotides which hybridize 3o specifically side by side to the complementary DNA sequence thereby positioning the two labels next to each other.
The basic principles of the present invention are outlined in Fig.I.
Figure l: Shows the steps involved in an assay for amplified DNA
applying interactive labels and a backfolding primer of the general 35 formula I and a probe of the general formula II. The 2~~~~Q~
complementary strand of the double strand is omitted for simplification.
In the present invention the amplification may be carried out by a combination of two primers of which at least one is a primer of the general formula I, also named backfolding primer due to the ability of its subsequence Pc to fold back to the primer part Pp yielding a short double strand.
It is known in the art that selfcomplementary parts in oligonucleotides may cause problems in hybridization steps with a second oligonucleotide, especially if the first oligonudeoHde is intended for use as a primer in a chain to extension reaction preferably with an enzyme (polymerase). Therefore, it is usually recommended for a clean reaction to optimize these primers and also probes in such a manner that they do not contain such self complementary parts.
It has now unex_-~ectedly been found that oligonucleotides containing selfcomplementary regions may be advantageously used in a polymerase chain reaction and in a detection step.
In case of the primer with formula I the primer part Pp from the 3'-end up to the nonnucleotidylic linker group represents a standard primer for the amplification of the target DNA sequence to be detected. At the temperature of 2o denaturation and subsequent utilization of a polymerase at least part of the backfolding primer exists in the open form and can thus prime speafically its template-dependent extension in the presence of adequate amounts of the four deoxyribonucleoside triphosphates (dATP, dGTP, dTTP and dCTP) or analogs.
Known DNA polymerases include, for example, E. coli DNA polymerase I or its Klenow fragment, T4 DNA polymerase, Taq DNA polymerase, Tth DNA
polymerase from Thermus thermophilus and DNA polymerase from Thermococcus litoralis. The reaction conditions for catalyzing DNA synthesis with these DNA polymerases are well known in the art.
Any amplification method based on a chain extension reaction may be 3o employed which allows the incorporation of the primer I in the amplification product. Amplification by the polymerase chain reaction (PCR) has already been mentioned. The primer of formula I may also be used in alternate methods of producing amplified target sequences. For example, the primer I
may be used together with a second oligonucleotide which are both complementary to a DNA template and are directly adjacent to one another _5_ with their 3'- and 5'-ends. Amplification occurs through repeated denaturation, primer annealing and ligation of the 3'- and 5'-ends. The so called ligase chain reaction (LCR) or ligase amplification reaction (LAR) is further described by Wu and Wallace in Genomics 4 560-569 (I988). The amplification products containing the labeled primer of formula I may then be detected by hybridizing a labeled probe of formula II near to the backfolded piece Pc as described in the next paragraphs. Amplification by PCR is the preferred method.
The denaturation temperature is about 90° - ?00° C whereas the temperature for the polymerase reaction is usually lower and depends on the polymerase used. In case of the Taq polymerase the temperature is usually between 70° - 80° C which is high enough to prevent complete internal backfolding of the short sequence Pc to Pp in primer I which otherwise may inhibit the primer activity. After amplification and at low temperature the ~5 incorporated primer especially its part Pc can fold back. With a probe of formula II (detection oligonucleotide) hybridizing to the amplified region and equipped at its 3'-end with one or more energy donor molecules (if X in the = -primer of formula I is an energy acceptor) or an energy acceptor molecule (if X
in the primer of formula I is an energy donor molecule) the backfolding guarantees a short distance between the donor or the acceptor at the 5'-end of the backfolding primer allowing in such a situation an energy transfer (Figure 1, step b)). If the target sequence is not present and therefore has not been amplified by primer I, this energy transfer is not possible since there is no primer extension product to which the detection oligomer could hybridize.
Therefore a clearcut distinction between the presence of the amplified target or its absence is possible. Thus a test could be carried out directly after amplification in a homogeneous fashion without having to perform separation steps and an energy transfer indicates the presence of the amplified target sequence.
Primer I may be of any length suitable for amplification arid detection.
Primer region Pp has preferably a length of about IO - 30 nucleotides but may be shorter or longer, depending on the sequence to be detected. Parameters for designing sequence and temperature specific PCR primers are known in the art taking into account the stability of the individual base pairings of the nucleotide bases.

The primer part Pp used herein is selected to be "substantially"
complementary to each specific sequence to be amplified. The primer part Pp need not reflect the exact sequence of the template, but must be sufficiently complementary to selectively hybridize with their respective strands even at the temperature of polymerisation. Non complementary bases or longer sequences can be interspersed into the primer part Pp provided that this part retains sufficient complementarity with the sequence of one of the strands to be amplified to hybridize therewith, and to thereby form a duplex structure which can be extended by the polymerizing agent. Primer part Pc will be 1o adapted in each case to be partially or completely complementary to the sequence of Pp. Preferably primer part Pp reflects the complementary sequence of the template.
The addition of the backfolding part Pc together with the label has been found to be not at all detrimental for the primer function. The sequence of Pc may have any length relative to Pp. Preferably Pc is shorter than Pp by a few bases. This precludes that, in case of a longer primer part Pc, this part binds more tightly than Pp to the complementary sequence of the template at the amplification temperature. Additional donor molecules can span the gap between 3'-end and 5'-end, which means that there is no need for the 3'-end of 2o the probe II to start exactly where the 5'-end of the backfolded primer I
ends.
Additionally, primer part Pp should not be too long in relation to Pc to avoid that the probe, at lower temperatures, hybridizes to the backfolded primer I without its prior elongation, which may cause false positive results.
As an example, the primer part Pp is 18 bases in length and may fold back by bases of part Pc. This is also depending on the composition of the bases in the sequence.
The second oligonucleotide primer (counter primer) commonly used for coamplification of the other (complementary) nucleic acid sequence may also be labeled and used in equal or different amounts than primer I. If both 3o primers are labeled, almost all oligonucleotides of the amplified sequence will be labeled and may be detected using at least one 3'-labeled probe II which allows hybridization near to the backfolded part Pc of at least one of the nucleic acid sequences which have to be detected after amplification. Other variations or combinations of the primers of the invention and the probes described are within the scope of the present invention such as, for example, the use of ~Q~O~~~
_7_ differently labeled primers, single strand amplification or RNA amplification instead of DNA.
Alternatively one can also place one or more of the donor molecules at the 5'-end of the backfoldirg oligomer and the acceptor molecules at the 3'-end of the detection oligomer as shown schematically in Figure 1, step c).
Preferably the primer will be labeled with the energy donor at the 5'-end. This may be advantageous due to the background fluorescence of the energy acceptor resulting from direct excitation. In PCR the primers are applied in large excess.
Thus, if the primer is labeled with the energy acceptor (e.g. the Ru complex), this fluorescence caused by direct excitation may become important.
The detection of the energy transfer between the donor and the acceptor by fluoresence measurements may be performed by methods known in the art.
The methodology of the time-resolved fluorescence technique is described, for example, in the German Offenlegungsschrift No. 2628158 and in the European i5 Patent Application, Publ. No. 178 450.
Interactive molecules may be used in any combination in the present invention, provided that they are chemically bonded or complexed to the primer or the probe without affecting the optical properties of these molecules and that they are clearly detectable in the presence of DNA. Suitable interactive molecules are glucose oxidase/peroxidase; fluorescein/rhodamin and ., salicylate/terbium complex. The donor/acceptor combination lumazine chromophore/bathophenanthroline-ruthenium-II-complex is preferred.
The backfolding primer also contains a nonnucleotidylic group L which allows a base pairing of the complementary bases in Pc and Pp, thereby avoiding loop formation. This nonnucleotidylic group leads also to a stop of the polymerise at this position during the amplification process.
The nonnucleotidylic group L is selected so as to allow efficient backfolding between the sequence Pp and its complementary sequence Pc. This group L may consist of any kind of nonnucleotidylic linkers which allow defined backfolding of Pc to Pp without loop formation. Preferably the nonnucleotidylic linker is derived from propanediol. More preferably the linker group L consists of two propanediol units linked together by a phosphate group and attached via phosphate groups to the oligonucleotide sequences Pc and Pp. The most preferred linker group L has the following formula:

2~~~~~~~
_8_ -O-P(O)2-O-(CH~3-O-P(O)2-O-(CH~3-O-P(O)2-O- Linker group L
This nonnucleotidylic linker has been found unexpectedly to allow efficient backfolding of Pc to Pp and additionally to avoid amplification of the backfolding part Pc.
The following description serves to illustrate some of the steps involved in the preparation of the labeled primers and probes and performing the process of the present invention.
The oligonucleotides which act as normal primers in the polymerase reaction or the oligonucleotides which are parts of the modified primers or probes can be synthesized by methods known in the art (M.J. Gait (Ed.), DNA
Synthesis - A Practical Approach, IRL-Press, 1984). Solid phase synthesis using (i-cyanoethyl phosphoramidites as described by N.D. Sinha et al., in Nucleic Acids Research 12, 4539-4557 (I984) is preferred.
The group L may be inserted in the course of the solid phase synthesis of the primer part Pp with the phosphoramidite 5 or analogs thereof. The synthesis of 5 is described by F. Seela in Nucleic Acids Research I5, 3113 (1987).
O(CH2)2CN
(Me0)2Tr-O(CHZ)30-P~
N{iPr)2 5 Adding two of these amidites S to the oligonucleotide Pp during the synthesis yields the most preferred linker which will be further elongated during the synthesis with the appropriate nucleoside phosphoramidites to add the backfolding part Pc of the primer of formula I.
The labels selected for coupling at the 3'- or 5'-OH group at the end of the primer or probe may be coupled either directly or aftex modification of these hydxoxy groups into a -NH2, -COOH, -SH or any other suitable group with methods known in the art. The attachment of the labels may be done both if the oligonucleotide is still bonded to the support or if it is already cleaved off.
The labels may also be introduced in one or more of the nucleotide bases of the primers or probes prior to their attachment to the growing oligonucleotide chain in form of, for example, nucleoside amidites. In case of Ru complex/lumazine labels the lumazine group may be introduced at the 5'-end of the backfolding primer or at the 5'-/ 3'-end of the probe using the phosphoramidite 7 of the 6,7-dimethyl lumazine-2'-deoxyriboside. Other lumazine derivatives or coupling reagents for the introduction of the phosphate group may also be used.

~~ NyCH3 O N I N~~CH~
(Me0)ZTrO O
O
I
NC-(CH2)2- O-P' N(iPr)2 7 One or more of these molecules bearing the lumazine chromophore may be introduced in the oligonucleotide to enhance the energy transfer. Preferred are one to four consecutive lumazine chromophores. The synthesis and introduction of the lumazine ribosides either at the 3'- or 5'-end of an oligonudeotide is described in the European Patent Application, Publ. No. 439 036.
to Various Ru complexes as energy acceptors together with different spacers between the complex and the DNA molecule may be used as described in the European Patent Applications, Publ. Nos. 340 605 and I78 450. For the attachment of the Ru complex at the 5'-end of the backfolding primer a phoshoramidite of structure 6a or a reagent of structure 6b may be used as an example. Preferably the derivative 6b may be employed for the introduction at the 3'-end.

2a~Q~~

6a ~ N ~O(CHz)ZCN
(CHz)s-O-P~
N(iPr)z O
~ (CHz)5-COON
O~
6b The reagent 6a can be used without further modifications for coupling to e.g. a hydroxy or amino group in the course of the solid phase synthesis of the oligonucleotide.
Coupling of reagent 6b at the 3'-end may be performed after some modifications of the solid support used for the synthesis. The general scheme is outlined below (Scheme 1) starting with compound 8 which is described by 1o Nelson et al. in Nucleic Acids Research 17, 7179 (1989). For further details including the attachment of the Ru complex derivative 6b to the modified support 10 see Example 2.

O
O
(Me0)2Tr-O ;HZ (Me0)2Tr-O iH2 CHOH CHO -C(CHZ)ZCOOH
Fmoc-NHCfi2 Fmoc-~lHCH2 g MSNT H2N,,~ww~CPG
Melm (Me0)zTr-pCHz O
a CHO-C(CHZ)z CONH LPG
Scheme 1 Fmoc-NHCHz 10 The invention will be further illustrated by the following examples without limiting it to them.
Example I
Synthesis of Lumazine and Ru complex phosphoramidites The phosphoramidite of the 6,7-dimethyl-lumazine-2'-deoxyriboside was prepared as described in European Patent Application, Publication No. 439 036 (July 31, 1991). The phosphoramidite 6a of the Ru complex was prepared in situ as described by W. Bannwarth and D. Schmidt in Tetrahedron Letters 30 1513-1516 (1989).
The Ru complex derivative 6b was prepared by coupling the Ru complex with activated N-hydroxysuccinimide as described in European Patent Application, Publ. No. 340 605 or by W. Bannwarth et al., in Helvetica Chimica Acta 71 2085-2099 (I988). N,N,N',N'-tetramethyl (succinimido) uronium tetrafluoroborate (TSTU) was used as an activating agent. The synthesis and use of TSTU is described by R. Knorr et al., in Tetrahedron Letters 30, 1927-(1989) and W. Bannwarth in Tetrahedron Letters 32, l I57-1160 (1991 ).

2Q~~~~~~

Synthesis of 1-O-(4 4'-dimethoxytritXl)-3-O-((N N-diisopropylamino)-b-c~ranoethox -,~phos~hino)-1 3-pro~anediol 5 This reagent was prepared in a two step procedure as described by F. Seeia and K. Kaiser in Nucleic Acids Research I5, 3113-3129 (1987) starting from 1,3-propanediol which was first protected by a 4,4'-dimethoxytrityl group. This was followed by a phosphinylation with ((i-cyanoethoxy) bis (diisopropylamino) phosphine in the presence of diisopropylammonium tetrazolide to yield 5.
Example 2 SXnthesis of 3'-Ru complex modified DNA
The synthesis of the modified CPG support for the solid phase synthesis of 3'-modified oligonucleotides was done as outlined in Scheme 1 (supra).
Compound 8 was prepared according to procedures described by Nelson et al., in Nucleic Acids Research 17, 7179-7186 and 7187-7194 (1989).
In the next step compound 8 (lOmmol; 6.16 g) was evaporated three times ~5 from anh. pyridine. Then it was dissolved in 60 rnl of anh. pyridine and 25 mmol (2.50 g) of succinic acid anhydride and 10 mmol (1.22 g) of 4-dimethylaminopyridin (DMAP) were added and stirred under argon. After 4 h the reaction was finished (TLC). The reaction mixture was taken up in 200 ml of diethylether and extracted four times with sat. brine. The organic layer was dried over Na2S04 and evaporated, which yielded 6 g of an oil.
Purification by short column chromatography (CC) on 150 g of silica gel (0,003-0,040 nm (Merck)) with 1000 ml of a mixture CH2Cl2/MeOH/pyridine (94:5:1;
v/v), 500 ml of CH2C12/MeOH/pyridine (92:7:1) and 500 ml of CH2C12/MeOH/pyridine (89:10:1). Pure fractions were collected and preapitated from n-pentane yielding 2.3 g of pure 9. M.p. 87-89 ~C. Anal.
calculated for C43H4~N09 ~ 0.2 n-pentane: C 72.37, H 5.99, N 1.92; found: C
72.60, H 6.14, N 1.94.1H-NMR (CDC13): 2.64 (s, OCCH2CH2C0); 3.03-3.50 (2m, CH2-CH-CH2); 3.50-3.65 (m, CH2-CH-CH2); 3.74 (s, 2 OCH3); 4.19 (t, CH2-CH); 4.34 (d, CH); 6.81 (d, 4 arom. H ,C~); 7.15-7.37 (m, 9 arom. H, C6H5,C~); 7.39 (t, fluorenyl); 7.5I (d, fluorenyl); 7.76 (d, fluorenyl).
Preparation of the functionalized support 10: The CPG-support (Pierce) was evaporated from anh. pyridine. Then it was dissolved in 10 ml of anh.
pyridine and 0.60 mmol (430 mg) of 9 as well as 3 mmol (880 mg) of 1 (mesitylen-2-sulfonyl)-3-nitro-1H-I,2,4-triazole (MSNT) and 0.3 ml of 2~~~~~~

N-methyl imidazole (NMI) were added, and the suspension was allowed to react at room temperature with occasional shaking. After 2 h it was filtered off and washed successively with pyridine, DMF and ether. To the support 10 ml of a mixture of Ac20/pyridine (1/10; v/v) containing 1% DMAP was added.
After 1 h it was filtered off and the support washed with pyridine, DMF, ethanol and ether. The degree of functionalization of 10 was determined by photometric determination of the dimethoxytrityl cation (30.5 mmol / g) and after cleavage of the fluorenylmethoxycarbonyl (Fmoc) group followed by photometric determination at 300nm (30.1 mmol/g).
Preparation of the 3'-amino modified DNA on support 10 : The synthesis was carried out on a synthesizer starting with 1.5 mmol of support 10. A
tenfold excess of the corresponding phosphoramidites was applied during each cycle. After synthesis the support was washed with acetonitril and ether, and dried. Then 20 mg of the support were treated with 700 ~.1 of cone. ammonia for 1.5 h at 67~C in a tightly closed Eppendorf tube. The suspension was filtered and the filtrate taken to dryness. The pellet obtained was dissolved in 300 ~,1 of 80 % acetic acid and after 2 h 700 Etl of ether were added to precipitate the DNA.
After centrifuging ,the pellet was dissolved in water and after addition of mmol of KCl it was dialysed against 21 of water (excl. MW 1000). UV
absorbancy indicated a yield of 53 OD units of amino modified DNA, which was used as such for the coupling to the Ru complex.
Coupling of 6b to the amino modified DNA: In an Eppendorf tube 27.5 OD units of the 3'-amino modified DNA and 4 mmol (3mg) of 6b were reacted in a mixture of 200 ltl of DMF, 200 ltl of dioxane, 200 ~.1 of water and 5 p1 of Hurugs base. The mixture was allowed to react for 16 h with shaking in the dark. It was taken to dryness in a speed vac concentrator and dissolved in 500 ~,1 of water. The solution was extracted 3 times with 500 ~.1 of CHCl3 to remove the excess of Ru complex. The purification was performed by polyacrylamide gel electrophoresis followed by electroelution.
3p Example 3 Synthesis of the oligonucleotides with a nonnucleotidylic linker and/or 3' or 5' modifications.
Oligonucleotides without modifications were prepared on controlled pore glass (CPG, Pierce) and applying ø-cyanoethyl phosphoramidites of the appropriate building blocks. 3'-Lumazine modified oligonucleotides were 20~0~04 prepared by elongation of lumazine-2'-deoxyriboside modified CPG-support as described in European Patent Application, Publ. No. 439 036. This application also describes methods and reagents for use in the synthesis of 5'- lumazine and 5'-Ru complex-modified oligonucleotides.
The nonnucleotidyl linker group consisting of two propanediol units separated by a phosphate group was inserted in the course of the solid phase synthesis with the corresponding phosphoramidite 5. Coupling of this amidite was performed twice, using a 10 fold excess and about 3 minutes coupling time together with tetrazole as activating agent.
1o The addition of the Ru complex at the 3'-end was performed with the Ru complex derivative 6b after the synthesis and deprotection of the oligonucleotide as described in Example 2.
Example 4 Polymerase chain reaction with a primer of the general formula I.
~5 Several oligonucleotides were synthesized and tested for their ability to act as primers in the polymerase chain reaction. The DNA fragment selected for amplification is part of the gag region of HIV-I. Conventional primers with (16) or without (14,15) a Ru complex at the 5'-end as well as modified primers of the general formula I (17,18) were synthesized with methods already 2o described.
The primers had the following specific sequences:

~0~~~~

s~A-T-A-A-T-C-C-A-C-C-T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T3. 1 4 5~T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T3. 1 5 5~Ru-T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T3. 1 6 T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T3. 1 7 A-T-A-G-G-G-T-C-A-T5~
T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T3. 18 A-T-A-G-G-G-T-C-A-T-RuS
In each case the second primer or counter primer used for coamplification of the complementary strand had the following sequence:
5~T-T-T-G-G-T-C-C-T-T-G-T-C-T-T-A-T-G-T-C-C-A-G-A-A-T-G-C3. 1 9 These oligonucleotides were derived from primer and probe sequences already described in Table 2 of C.H. 0u et al., in Science 239, 295-297 (1988).
Per amplification reaction 1000 copies of HIV plasmid DNA were applied.
The primers were used in excess at 100 pMoles. In case of 19 50 pMoles were applied. The HIV DNA was amplified in duplicate and a PCR negative control was incorporated. Amplification with primers 14 and 19 was used as positive control.
50 u1 of HIV DNA were added to 50 ~.1 master mix for a total volume of 100 ~.l per reaction mixture.
Master mix: Distilled water 27.5 u1 lOxTaq buffer I0.0 ~.I

8 mM dNTP I0.0 ~.1 100 mM primer (14-18) 3.0 ~tl 50 mM primer 19 3.0 ltl Taq polymerase 0.5 1t.1 2o The efficiency and the homogeneity of the amplified DNA was tested by Southern hybridization (E.M. Southern, Journal of Molecular Biology 98, 503 (I975), using the radio labeled probe 5' ATC CTG GGA TTA A3'. The hybridizations were all carried out in a phosphate-buffered saline solution (10 mM inorganic phosphate; 1M NaCI, pH 7.0) with the oligonucleotides in equimolar ratio. Even the shortest backfolding primer equipped at the 5'-end with a Ru complex leads to a specific amplification comparable in efficiency with a standard nonmodified primer.
Example 5 Detection of elongated backfoldin~;~rimers via h~rbridization and enerQv transfer 1o It was determined whether a backfolding primer of the general formula I
after its elongation in a polymerase chain reaction is able to serve as a template for subsequent detection with an oligonucleotide probe of the general formula II. 5'-Ru-complex-labeled oligonucleotide 1 serves as a synthetic model com-pound for an elongated primer of structure I which acts as a template for 3-~5 lumazine-labeled probes 2a, 2b and 2d and negative probe 2c.
C-C-A-A-A-C-T-C-C-G-A-T-A-A-T-C-C-A-C-C-T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T3~

G-G-T-T-T-G-A-G-G-C T-A-T-T-A-G-G-T-G-G-A-T-A-G-G-G~~T 2 a Ru Lu4 Energy transfer d(Lu4-A-G-G-T-G-G-A-T-A-G-G-G-T-C-A-T-C) 2 b d(Lu4-G-C-C-A-C-T-T-G-T-A-T-G-C-A-A-C-T) 2 C
Controls d(T-A-T-T-A-G-G-T-G-G-A-T-A-G-G-G-T) 2 d nonnucleotidylic linker Hybridizations were all carried out in a phosphate-buffered saline solution (10 mM inorganic phosphate; 1 M NaCl, pH 7.0) with oligo-nucleotides in equimolar ratio.
20 Fluorescence measurements were performed on a SLM Model 4043 S
spectrofluorometer. Excitation and emission wavelengths were set at 337 nm 2Q~~~~~

and 620 nm, respectively. The concentrations of the hybrids were 1.3 ~ 10-~ M
for a sample volume of 400 ~.1.
Table 1 shows the results of the energy transfer measurements. As expected, the results were positive in case of probes 2a and 2b and negative in case of probes 2c and 2d.
Hybrid 1F/ lF2 1 /2a 2.1 I /~ 2.I
I /2c 1.0 l0 1/2d 1.2 Table I
The fluorescence resulting from the energy transfer (IF3) was defined as being the difference between the measured fluorescence at 620 nm (IF) minus the fluorescence of the Ru complex through direct excitation (IF2) and the fluorescence of the lumazine chromophore at 620 nm (IFS), which can be neglected. Therefore the formula for the intensity of the energy transfer reduces to: IF3=IF-IF2. For the sake of simplicity we have shown in Table 1 only the ratio of the measured fluorescence intensity IF at 620 nm in relation to the fluorescence intensity of the Ru complex due to direct excitation (IF2).
2o The reversed energy transfer system utilizing a 5'-lumazine-labeled primer and a 3'-Ru complex-labeled probe was investigated with the model compounds 11,12 and 13.

_I8_ T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T-T-T-A-T-A-A-A-A-G-A-T-G-G-A-T-A-A3. 7 1 A-T-A-G-G-G-T-C-A-T-Lus Ru-T-A-A-A-T-A-T-T-T-T-C-T-A-C-C-T-A-T-T5~ 1 2 energy transfer T-A-T-C-C-C-A-G-T-A-G-G-A-G-A-A-A-T-T-T-A-T-A-A-A-A-G-A-T-G-G-A-T-A-A3. 1 3 A-T-A-G-G-G-T-C-A-T-C-C-T-C-T-T
Ru-T-A-A-A-T-A-T-T-T-T-C-T-A-C-C-T-A-T-T5~ 1 2 no energy transfer The results obtained with the primer/probe systems 11/12 (showing energy transfer) and 13/12 as a negative control with no energy transfer confirmed the utility of this combination although the efficiency for the energy transfer was a bit lower. (data not shown).

Claims (17)

1. A process for amplifying and detecting at least one specific nucleic and sequence in a sample containing a nucleic acid or a mixture of nucleic ands at least one of which is suspected of containing said sequence, which process comprises:
a) amplifying the nucleic acid sequence to be detected by means of a chain extension reaction utilizing a first oligonucleotide primer of the general formula I

X - Pc - L - Pp (I) wherein Pp is an oligonucleotide sequence substantially comple-mentary to a part of one strand of the nucleic and sequence to be detected, Pc is an oligonucleotide sequence substantially comple-mentary to the sequence Pp, L is a non-nucleotidylic linker group selected so as to allow efficient backfolding between the sequence Pc and the primer extension sequence of Pp and to avoid amplification-of the backfolding part Pc, and X is an energy donor or acceptor, and a second oligonucleotide primer substantially complementary to a part of the other strand of the nucleic acid sequence to be detected;
b) separating after the last amplification cycle the primer extension products of step (a) from their complementary sequences to produce single-stranded molecules containing a primer of formula I;
c) treating said single-stranded molecules containing the primer of formula I
above with an oligonucleotide probe of the general formula II

Y - Pr (II) wherein Y is an energy acceptor, when X in the primer of formula I
is an energy donor, or Y is an energy donor, when X in the primer of formula I is an energy acceptor, and Pr is an oligonucleotide sequence complementary to a part of the amplified single-stranded molecules containing the primer of formula I above and selected so as to guarantee a short distance between X and Y after backfolding of the sequence Pc and hybridization of the sequence Pr to said single-stranded molecules such that an energy transfer can take place, under conditions allowing hybridization of the sequences Pc by backfolding and of Pr to said single-stranded molecules containing a primer of formula I; and d) determining whether an energy transfer takes place as a means for detecting presence or absence of the nucleic acid to be detected.
2. A process according to claim 1, wherein X is an energy donor and Y is an energy acceptor.
3. A process according to claim 1, wherein X is an energy acceptor and Y is an energy donor.
4. A process according to any one of claims 1 to 3, wherein the energy donor is a lumazine chromophore and the energy acceptor is a bathophenan-throline-ruthenium-II-complex.
5. A process according to any one of claims 1 to 4, wherein L consists of two propanediol units linked together by a phosphate group and attached via phosphate groups to the oligonucleotide sequences Pc and Pp.
6. A process according to any one of claims 1-5, wherein the chain extension reaction is a polymerase chain reaction.
7. A primer of the general formula X-Pc-L-Pp (I) wherein Pp is an oligonucleotide sequence substantially complementary to a part of one strand of a nucleic acid sequence to be detected, Pc is an oligonucleotide sequence substantially complementary to the sequence Pp, L is a non-nucleotidylic linker group selected so as to allow efficient backfolding between the sequence Pc and a primer extension sequence of Pp obtained by amplification using a polymerase chain reaction and to avoid amplification of the backfolding part Pc, and X is an energy donor or acceptor.
8. A primer according to claim 7, wherein X is an energy donor.
9. A primer according to claim 7, wherein X is an energy acceptor.
10. A primer according to claim 7 or 8, wherein X is a lumazine chro-mophore.
11. A primer according to claim 7 or 9, wherein X is a bathophenanthroline-ruthenium-II-complex.
12. A primer according to any one of claims 7 to 11, wherein L consists of two propanediol units linked together by a phosphate group and attached via phosphate groups to the oligonucleotide sequences Pc and Pp.
13. A diagnostic kit for amplifying and detecting at least one specific nucleic acid sequence in a sample containing a nucleic acid or a mixture of nucleic acids at least one of which is suspected of containing said sequence, which kit comprises a primer of the formula X - Pc - L - Pp (I) wherein Pp is an oligonucleotide sequence substantially complementary to a part of one strand of the nucleic acid sequence to be detected, Pc is an oligonucleotide sequence substantially complementary to the sequence Pp, L is a non-nucleotidylic linker group selected so as to allow efficient backfolding between the sequence Pc and the primer extension sequence of Pp and to avoid amplification of the backfolding part Pc, and X is an energy donor or acceptor, and, a probe of formula II as defined in claim 1 and means and reagents for amplification and detection of said sequence using a polymerase chain reaction.
14. A nonnucleotidylic linker group comprising:

-O-P(O)~-O-(CH2)3-O-P(O)~-O-(CH2)3-O-P(O)~-O-
15. A nonnucleotidylic linker group of claim 14 of the formula -O-P(O)~-O-(CH2)3-O-P(O)~-O-(CH2)3-O-P(O)~-O-
16. A reagent for use in the amplification and detection of at least one specific nucleic acid sequence in a sample containing a nucleic acid or a mixture of nucleic acids at least one of which is suspected of containing said sequence, said reagent comprising a primer of formula I as defined in any one of claims 7 to 12.
17. A diagnostic kit for use in the amplification and detection of at least one specific nucleic acid sequence in a sample containing a nucleic acid or a mixture of nucleic acids at least one of which is suspected of containing said sequence, said kit comprising:
a) at least one of a primer of formula I as defined in any one of claims 7 to 12; and b) a probe of the general formula II

Y-Pr (II) wherein Y is one of an energy acceptor, when X in the primer of formula I is an energy donor, and an energy donor, when X
in the primer is an energy acceptor, and Pr is an oligonucleotide sequence complementary to a part of an amplified single-stranded molecule containing the primer of formula I and selected so as to guarantee a short distance between X and Y after backfolding of the sequence Rc and hybridization of the sequence Pr to said single stranded molecule such that an energy transfer can take place.
CA002090904A 1992-03-23 1993-03-03 Dna detection method Expired - Lifetime CA2090904C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92104956.5 1992-03-23
EP92104956A EP0566751B1 (en) 1992-03-23 1992-03-23 DNA detection method

Publications (2)

Publication Number Publication Date
CA2090904A1 CA2090904A1 (en) 1993-09-24
CA2090904C true CA2090904C (en) 2004-08-10

Family

ID=8209457

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002090904A Expired - Lifetime CA2090904C (en) 1992-03-23 1993-03-03 Dna detection method

Country Status (9)

Country Link
US (1) US5573906A (en)
EP (1) EP0566751B1 (en)
JP (1) JP3771281B2 (en)
CA (1) CA2090904C (en)
DE (1) DE69207580T2 (en)
DK (1) DK0566751T3 (en)
ES (1) ES2082256T3 (en)
GR (1) GR3019617T3 (en)
IE (1) IE72498B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6809196B2 (en) 1994-09-26 2004-10-26 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US7655129B2 (en) 1998-06-23 2010-02-02 Osmetech Technology Inc. Binding acceleration techniques for the detection of analytes
US8012743B2 (en) 1998-10-27 2011-09-06 Osmetech Technology Inc. Detection of target analytes using particles and electrodes
US8486247B2 (en) 1999-04-21 2013-07-16 Osmetch Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes

Families Citing this family (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081226B1 (en) 1996-06-04 2006-07-25 University Of Utah Research Foundation System and method for fluorescence monitoring
US5935522A (en) * 1990-06-04 1999-08-10 University Of Utah Research Foundation On-line DNA analysis system with rapid thermal cycling
US7273749B1 (en) 1990-06-04 2007-09-25 University Of Utah Research Foundation Container for carrying out and monitoring biological processes
US6576419B1 (en) * 1993-07-23 2003-06-10 University Of Utah Research Foundation Assay procedure using fluorogenic tracers
US5952172A (en) 1993-12-10 1999-09-14 California Institute Of Technology Nucleic acid mediated electron transfer
US5824473A (en) * 1993-12-10 1998-10-20 California Institute Of Technology Nucleic acid mediated electron transfer
US5591578A (en) * 1993-12-10 1997-01-07 California Institute Of Technology Nucleic acid mediated electron transfer
US6071699A (en) 1996-06-07 2000-06-06 California Institute Of Technology Nucleic acid mediated electron transfer
EP1179600B1 (en) * 1996-06-04 2005-05-11 University Of Utah Research Foundation Monitoring hybridization during PCR
ES2215230T3 (en) * 1996-06-04 2004-10-01 University Of Utah Research Foundation SYSTEM AND METHOD FOR CARRYING OUT AND SUPERVISING CHAIN POLYMERASE REACTIONS.
US6444423B1 (en) 1996-06-07 2002-09-03 Molecular Dynamics, Inc. Nucleosides comprising polydentate ligands
US7070925B1 (en) 1996-07-16 2006-07-04 Gen-Probe Incorporated Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6117635A (en) * 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6130038A (en) * 1996-07-16 2000-10-10 Gen-Probe Incorporated Method for amplifying target nucleic acids using modified primers
US5853990A (en) 1996-07-26 1998-12-29 Edward E. Winger Real time homogeneous nucleotide assay
AU4321497A (en) * 1996-09-27 1998-04-17 Laboratory Of Molecular Biophotonics Probes for detecting polynucleotides and detection method
US7045285B1 (en) 1996-11-05 2006-05-16 Clinical Micro Sensors, Inc. Electronic transfer moieties attached to peptide nucleic acids
US7381525B1 (en) 1997-03-07 2008-06-03 Clinical Micro Sensors, Inc. AC/DC voltage apparatus for detection of nucleic acids
US7014992B1 (en) * 1996-11-05 2006-03-21 Clinical Micro Sensors, Inc. Conductive oligomers attached to electrodes and nucleoside analogs
US6096273A (en) * 1996-11-05 2000-08-01 Clinical Micro Sensors Electrodes linked via conductive oligomers to nucleic acids
US7160678B1 (en) 1996-11-05 2007-01-09 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
US7393645B2 (en) * 1996-11-05 2008-07-01 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
US7803528B1 (en) 1997-02-28 2010-09-28 Quest Diagnostics Incorporated Fluorescence energy transfer by competitive hybridization
US6391622B1 (en) 1997-04-04 2002-05-21 Caliper Technologies Corp. Closed-loop biochemical analyzers
US6235471B1 (en) 1997-04-04 2001-05-22 Caliper Technologies Corp. Closed-loop biochemical analyzers
EP0972082A4 (en) * 1997-04-04 2007-04-25 Caliper Life Sciences Inc Closed-loop biochemical analyzers
US6013459A (en) 1997-06-12 2000-01-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US6342350B1 (en) * 1997-09-05 2002-01-29 The General Hospital Corporation Alpha-2-macroglobulin diagnostic test
US6485901B1 (en) 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
US6355421B1 (en) 1997-10-27 2002-03-12 Boston Probes, Inc. Methods, kits and compositions pertaining to PNA molecular beacons
US6686150B1 (en) 1998-01-27 2004-02-03 Clinical Micro Sensors, Inc. Amplification of nucleic acids with electronic detection
CA2319170A1 (en) 1998-01-27 1999-07-29 Clinical Micro Sensors, Inc. Amplification of nucleic acids with electronic detection
US7090975B2 (en) * 1998-03-13 2006-08-15 Promega Corporation Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
US6312902B1 (en) 1998-03-13 2001-11-06 Promega Corporation Nucleic acid detection
US6270974B1 (en) 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
US6277578B1 (en) 1998-03-13 2001-08-21 Promega Corporation Deploymerization method for nucleic acid detection of an amplified nucleic acid target
US6235480B1 (en) * 1998-03-13 2001-05-22 Promega Corporation Detection of nucleic acid hybrids
US6268146B1 (en) 1998-03-13 2001-07-31 Promega Corporation Analytical methods and materials for nucleic acid detection
US6391551B1 (en) 1998-03-13 2002-05-21 Promega Corporation Detection of nucleic acid hybrids
US6703211B1 (en) 1998-03-13 2004-03-09 Promega Corporation Cellular detection by providing high energy phosphate donor other than ADP to produce ATP
US6270973B1 (en) 1998-03-13 2001-08-07 Promega Corporation Multiplex method for nucleic acid detection
WO1999049293A2 (en) * 1998-03-24 1999-09-30 Boston Probes, Inc. Methods, kits and compositions pertaining to detection complexes
US6287772B1 (en) 1998-04-29 2001-09-11 Boston Probes, Inc. Methods, kits and compositions for detecting and quantitating target sequences
CA2335026A1 (en) * 1998-06-12 1999-12-16 Intergen Company Multi-fluorescent hairpin energy transfer oligonucleotides
GB9812768D0 (en) * 1998-06-13 1998-08-12 Zeneca Ltd Methods
US7087148B1 (en) 1998-06-23 2006-08-08 Clinical Micro Sensors, Inc. Binding acceleration techniques for the detection of analytes
US6290839B1 (en) 1998-06-23 2001-09-18 Clinical Micro Sensors, Inc. Systems for electrophoretic transport and detection of analytes
WO2000001850A2 (en) * 1998-07-02 2000-01-13 Gen-Probe Incorporated Molecular torches
US6740518B1 (en) 1998-09-17 2004-05-25 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes
US6833267B1 (en) 1998-12-30 2004-12-21 Clinical Micro Sensors, Inc. Tissue collection devices containing biosensors
US6322980B1 (en) 1999-04-30 2001-11-27 Aclara Biosciences, Inc. Single nucleotide detection using degradation of a fluorescent sequence
US20040248150A1 (en) * 1999-04-02 2004-12-09 Sharat Singh Methods employing oligonucleotide-binding e-tag probes
US6627400B1 (en) 1999-04-30 2003-09-30 Aclara Biosciences, Inc. Multiplexed measurement of membrane protein populations
US20020177135A1 (en) 1999-07-27 2002-11-28 Doung Hau H. Devices and methods for biochip multiplexing
US7312087B2 (en) 2000-01-11 2007-12-25 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
US7037654B2 (en) 1999-04-30 2006-05-02 Aclara Biosciences, Inc. Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
US7001725B2 (en) 1999-04-30 2006-02-21 Aclara Biosciences, Inc. Kits employing generalized target-binding e-tag probes
US20030235832A1 (en) * 2000-06-21 2003-12-25 Ahmed Chenna Multiplexed analysis by chromatographic separation of molecular tags
US6673550B2 (en) 1999-04-30 2004-01-06 Aclara Biosciences, Inc. Electrophoretic tag reagents comprising fluorescent compounds
EP1218541B1 (en) 1999-07-26 2008-12-10 Clinical Micro Sensors, Inc. Sequence determination of nucleic acids using electronic detection
GB9918237D0 (en) 1999-08-04 1999-10-06 Secr Defence Detection system
US20030207300A1 (en) * 2000-04-28 2003-11-06 Matray Tracy J. Multiplex analytical platform using molecular tags
US7537938B2 (en) * 2000-04-28 2009-05-26 Monogram Biosciences, Inc. Biomarker detection in circulating cells
US7160735B2 (en) * 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
US7771929B2 (en) * 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
US6753143B2 (en) 2000-05-01 2004-06-22 Clinical Micro Sensors, Inc. Target analyte detection using asymmetrical self-assembled monolayers
JP4382265B2 (en) * 2000-07-12 2009-12-09 日本電気株式会社 Method and apparatus for forming silicon oxide film
EP1377683A4 (en) * 2001-04-11 2004-09-08 Us Gov Health & Human Serv Modified random primers for probe labeling
WO2002095356A2 (en) * 2001-05-21 2002-11-28 Aclara Biosciences, Inc. Methods and compositions for analyzing proteins
WO2002094998A2 (en) 2001-05-21 2002-11-28 Aclara Biosciences, Inc. Analyzing phosphorylated proteins
GB0112868D0 (en) 2001-05-25 2001-07-18 Secr Defence Detection system
US7358052B2 (en) * 2001-05-26 2008-04-15 Monogram Biosciences, Inc. Catalytic amplification of multiplexed assay signals
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
EP1412522A1 (en) * 2001-06-15 2004-04-28 Quiatech AB Amplifiable probe
US20060252040A1 (en) * 2002-09-06 2006-11-09 Azlinda Anwar Strand specific detection and quantification
US8394944B2 (en) * 2002-09-20 2013-03-12 Siemens Healthcare Diagnostics Inc. Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation
CA2520538C (en) 2003-03-31 2014-04-29 F. Hoffmann-La Roche Ag Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup
US7820030B2 (en) 2003-04-16 2010-10-26 Handylab, Inc. System and method for electrochemical detection of biological compounds
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EP1680666A4 (en) * 2003-10-27 2008-03-26 Monogram Biosciences Inc Detecting human anti-therapeutic antibodies
EP2071031B1 (en) * 2004-08-27 2013-10-09 Gen-Probe Incorporated Single-primer nucleic acid amplification methods
US7713697B2 (en) * 2004-08-27 2010-05-11 Gen-Probe Incorporated Methods and kits for amplifying DNA
US7645575B2 (en) 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
JP5165383B2 (en) * 2004-12-23 2013-03-21 アイ−スタツト・コーポレイシヨン Molecular diagnostic system and method
CA2608151A1 (en) * 2005-05-11 2006-11-16 Stratagene California Snapback oligonucleotide probe
RU2005132940A (en) * 2006-03-01 2007-11-27 Институт биохимии и генетики Уфимского научного центра РАН (RU) METHOD FOR DETECTING SPECIFIC DNA OR RNA FRAGMENTS USING THE POLYMERASE CHAIN REACTION IN REAL TIME
US11001881B2 (en) 2006-08-24 2021-05-11 California Institute Of Technology Methods for detecting analytes
EP2489745B1 (en) * 2006-06-05 2017-01-11 California Institute Of Technology Real time micro arrays
US7833716B2 (en) 2006-06-06 2010-11-16 Gen-Probe Incorporated Tagged oligonucleotides and their use in nucleic acid amplification methods
JP2008029333A (en) * 2006-07-03 2008-02-14 Fujifilm Corp Primer for use in new gene amplification method
US11525156B2 (en) 2006-07-28 2022-12-13 California Institute Of Technology Multiplex Q-PCR arrays
WO2008014485A2 (en) * 2006-07-28 2008-01-31 California Institute Of Technology Multiplex q-pcr arrays
US7993832B2 (en) 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
US11560588B2 (en) 2006-08-24 2023-01-24 California Institute Of Technology Multiplex Q-PCR arrays
WO2008140484A2 (en) 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
US9938641B2 (en) * 2006-12-18 2018-04-10 Fluidigm Corporation Selection of aptamers based on geometry
US8183359B2 (en) * 2007-03-01 2012-05-22 Gen-Probe Incorporated Kits for amplifying DNA
EP3091088B1 (en) 2007-03-28 2019-02-06 Signal Diagnostics System and method for high resolution analysis of nucleic acids to detect sequence variations
US20100203572A1 (en) * 2007-06-13 2010-08-12 Attomol Gmbh Molekulare Diagnostika Method for carrying out and evaluating mix & measure assays for the measurement of reaction kinetics, concentrations and affinities of analytes in multiplex format
US10669574B2 (en) 2008-11-18 2020-06-02 XCR Diagnostics, Inc. DNA amplification technology
WO2011008530A2 (en) 2009-06-29 2011-01-20 Luminex Corporation Chimeric primers with hairpin conformations and methods of using same
EP2534263B1 (en) * 2010-02-09 2020-08-05 Unitaq Bio Methods and compositions for universal detection of nucleic acids
DE102010003781B4 (en) 2010-04-08 2012-08-16 Aj Innuscreen Gmbh Method for detecting specific nucleic acid sequences
GB201007867D0 (en) 2010-05-11 2010-06-23 Enigma Diagnostics Ltd Signalling system
WO2015054516A2 (en) * 2013-10-09 2015-04-16 Fluoresentric, Inc. Multiplex probes
KR102295290B1 (en) 2014-07-10 2021-08-30 플루어레센트릭 인코포레이티드 Dna amplification technology
US9708647B2 (en) 2015-03-23 2017-07-18 Insilixa, Inc. Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays
US9499861B1 (en) 2015-09-10 2016-11-22 Insilixa, Inc. Methods and systems for multiplex quantitative nucleic acid amplification
WO2017155858A1 (en) 2016-03-07 2017-09-14 Insilixa, Inc. Nucleic acid sequence identification using solid-phase cyclic single base extension
WO2018055577A1 (en) 2016-09-23 2018-03-29 Synthena Ag Mixed tricyclo-dna, 2'-modified rna oligonucleotide compositions and uses thereof
JP2020517613A (en) 2017-04-20 2020-06-18 シンセナ アーゲー Modified oligomeric compounds containing tricyclo DNA nucleosides and uses thereof
WO2018193428A1 (en) 2017-04-20 2018-10-25 Synthena Ag Modified oligomeric compounds comprising tricyclo-dna nucleosides and uses thereof
CN113924041A (en) 2019-03-14 2022-01-11 因斯利克萨公司 Method and system for fluorescence detection based on time gating
EP3978608A1 (en) 2020-10-05 2022-04-06 SQY Therapeutics Oligomeric compound for dystrophin rescue in dmd patients throughout skipping of exon-51

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565996B1 (en) * 1984-06-15 1988-01-22 Inst Nat Sante Rech Med CHEMICALLY MARKED NUCLEIC ACIDS, THEIR USE AND THE NECESSARY FOR ITS IMPLEMENTATION
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5215899A (en) * 1989-11-09 1993-06-01 Miles Inc. Nucleic acid amplification employing ligatable hairpin probe and transcription
CA2033692A1 (en) * 1990-01-25 1991-07-26 Wilhelm Bannwarth Energy transfer systems

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6809196B2 (en) 1994-09-26 2004-10-26 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US7655129B2 (en) 1998-06-23 2010-02-02 Osmetech Technology Inc. Binding acceleration techniques for the detection of analytes
US8012743B2 (en) 1998-10-27 2011-09-06 Osmetech Technology Inc. Detection of target analytes using particles and electrodes
US8486247B2 (en) 1999-04-21 2013-07-16 Osmetch Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US9151746B2 (en) 1999-04-21 2015-10-06 Osmetech Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US9557295B2 (en) 1999-04-21 2017-01-31 Osmetech Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes

Also Published As

Publication number Publication date
US5573906A (en) 1996-11-12
JP3771281B2 (en) 2006-04-26
EP0566751A1 (en) 1993-10-27
EP0566751B1 (en) 1996-01-10
JPH067199A (en) 1994-01-18
DE69207580T2 (en) 1996-08-08
DE69207580D1 (en) 1996-02-22
DK0566751T3 (en) 1996-03-04
ES2082256T3 (en) 1996-03-16
GR3019617T3 (en) 1996-07-31
CA2090904A1 (en) 1993-09-24
IE930219A1 (en) 1993-10-06
IE72498B1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
CA2090904C (en) Dna detection method
US5525494A (en) Amplification processes
JP4942484B2 (en) Fluorescent probe for DNA detection by hybridization with improved sensitivity and low background
US6087100A (en) Nucleic acid mediated electron transfer
US5547860A (en) Sulphocoumarin-containing nucleotides and their use in processes for detecting nucleic acids
JPH10510982A (en) Self-quenching fluorescent probes and methods
KR20000023814A (en) Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific tm
JPH09503660A (en) Nucleic acid detection by energy transfer
AU7871200A (en) Template-dependent ligation with PNA-DNA chimeric probes
JP2001514859A (en) Oligonucleotide probes with quenchable fluorescent labels and methods of use
JPH05508862A (en) large comb-shaped branched polynucleotide
CA2494571C (en) Oligonucleotides containing molecular rods
JPH10500572A (en) Method for detecting target nucleic acid
US6004826A (en) Repair-mediated process for amplifying and detecting nucleic acid sequences
JP3970816B2 (en) Fluorescent hybridization probe that lowers background
CA2495887C (en) Analyte detection
US20050042618A1 (en) Fluorescent resonance energy transfer probes
EP1035214B1 (en) A 3'-end modified nucleic acid probe, suitable for hybridization and detection via fluorescence
JP2003508064A (en) Methods for exogenous and internal control during nucleic acid amplification
Brown Development of novel fluorescent oligonucleotide probes for use in nucleic acid sequence analysis
McGuire Synthesis and studies of modified nucleotides and oligonucleotides

Legal Events

Date Code Title Description
EEER Examination request